Europe's medicines watchdog on Tuesday said the benefits of AstraZeneca's COVID-19 vaccine continue to outweigh the risks after several countries halted its use due to concerns about blood clots.
source https://www.cbc.ca/news/world/coronavirus-covid19-canada-world-march16-2021-1.5951243?cmp=rss
No comments:
Post a Comment